Your browser doesn't support javascript.
loading
Positive expression of programmed death ligand-1 correlates with superior outcomes and might be a therapeutic target in primary pulmonary lymphoepithelioma-like carcinoma.
Jiang, Li; Wang, Liang; Li, Peng-Fei; Zhang, Xin-Ke; Chen, Jie-Wei; Qiu, Hui-Juan; Wu, Xiao-Dong; Zhang, Bei.
Afiliação
  • Jiang L; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China ; VIP Region, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
  • Wang L; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China ; Department of Hematologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
  • Li PF; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China ; Department of Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
  • Zhang XK; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China ; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
  • Chen JW; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China ; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
  • Qiu HJ; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China ; VIP Region, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
  • Wu XD; Department of Integrative Medicine, Cancer Center of Guangzhou Medical University, Guangzhou, People's Republic of China.
  • Zhang B; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China ; VIP Region, Sun Yat-sen University Cancer Center, Guangzhou, People's Republic of China.
Onco Targets Ther ; 8: 1451-7, 2015.
Article em En | MEDLINE | ID: mdl-26109869

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Onco Targets Ther Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Onco Targets Ther Ano de publicação: 2015 Tipo de documento: Article